- Baxter (BAX +0.7%) has completed its acquisition of Gambro, a privately held global medical technology company based in Lund, Sweden.
- The total price tag on the deal was $3.9B, which was included in its Q3 and FY13 guidance.
- The acquisition gives BAX the opportunity to build upon its core portfolio and pipeline of investigational home hemodialysis and automated PD systems by adding Gambros dialyzers, devices and dialysis solutions, next-generation monitors, and acute therapies to treat patients with serious kidney, liver and lung conditions.
Baxter completes its acquisition of Gambro
Sep 6 2013, 12:29 ET